UnitedHealth Group Incorporated $UNH Shares Sold by Danske Bank A S

Key Points

• Danske Bank cut its UnitedHealth Group stake by 8.5% in the third quarter, selling 68,163 shares and retaining 734,347 shares valued at about $269.6 million.
• UnitedHealth reported quarterly earnings of $4.69 per share, beating the $4.14 consensus estimate, while revenue of $112.72 billion also topped forecasts but slipped 0.4% year over year.
• The company declared a quarterly dividend of $2.32 per share, equivalent to a 2.3% yield. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $463.93.

Danske Bank A S lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 734,347 shares of the healthcare conglomerate's stock after selling 68,163 shares during the quarter. UnitedHealth Group makes up 0.5% of Danske Bank A S's portfolio, making the stock its 29th biggest holding. Danske Bank A S owned approximately 0.08% of UnitedHealth Group worth $269,564,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. California First Leasing Corp bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $1,745,000. Dogwood Wealth Management LLC grew its holdings in UnitedHealth Group by 14.9% during the 3rd quarter. Dogwood Wealth Management LLC now owns 270 shares of the healthcare conglomerate's stock valued at $99,000 after buying an additional 35 shares in the last quarter. R.H. Investment Group LLC raised its position in shares of UnitedHealth Group by 1.7% during the third quarter. R.H. Investment Group LLC now owns 9,220 shares of the healthcare conglomerate's stock valued at $3,384,000 after buying an additional 154 shares during the last quarter. Rasp Wealth Solutions LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $214,000. Finally, Cornerstone Advisory LLC lifted its holdings in shares of UnitedHealth Group by 5.0% in the third quarter. Cornerstone Advisory LLC now owns 2,275 shares of the healthcare conglomerate's stock worth $835,000 after buying an additional 108 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 0.6%

NYSE UNH traded up $2.49 on Friday, hitting $407.62. 3,467,004 shares of the stock were exchanged, compared to its average volume of 5,162,694. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The firm has a market capitalization of $365.23 billion, a P/E ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The stock has a fifty day moving average price of $391.36 and a two-hundred day moving average price of $365.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio is currently 53.00%.

Key UnitedHealth Group News

These are some of the UNH news items that stood out recently:

• Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
• Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
• Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Wall Street Zen raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Bank of America reiterated a "buy" rating and issued a $450.00 price target on shares of UnitedHealth Group in a research note on Monday, July 20th. Stephens set a $500.00 price objective on shares of UnitedHealth Group in a report on Friday, October 16th. Raymond James Financial restated an "outperform" rating and set a $450.00 price objective on shares of UnitedHealth Group in a research report on Thursday, October 15th. Finally, New Street Research set a $402.00 target price on UnitedHealth Group in a report on Friday, October 9th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $463.93.

UnitedHealth Group Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.